EUVIMEDEUVIMED entdecken
Multizentrische Studie

Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteria

Stefan Krämer iD, Kristian Vogt iD, Martin Busch iD, Tobias Schmitt, Raoul Bergner iD, Sebastian Mosberger, Thomas Neumann, Teresa Maria Schreibing, Fabian Schumbrink, Thomas Rauen iD

Journal of Nephrology · 04.06.2026 · 39 (1) · 179-187

DOI: 10.1093/joneph/aajaf019 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Nephrology, online erschienen am 16.03.2026. Verfasst von Stefan Krämer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Clinical Immunology, RWTH Aachen University Hospital, Pauwelsstraße 30, Aachen 52074, Germany. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Decision Support Techniques, Glomerulonephritis, Granulomatosis with Polyangiitis. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Vifor Pharma Switzerland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glomerulonephritis is a common, organ-threatening manifestation in ANCA-associated vasculitis (AAV). Various clinico-histological scores have been developed assessing the risk of kidney failure, including the simplified ANCA kidney risk score (AKRiS).

Methods

This retrospective study included 220 patients with biopsy-confirmed kidney involvement of granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) recruited from four tertiary European referral centers. We collected biometric and clinical baseline data, disease activity parameters, AKRiS classes and histomorphological features. We examined the occurrence of a composite endpoint (ie all-cause mortality or kidney failure defined as persistent estimated glomerular filtration rate [eGFR] decline <15 mL/min/1.73 m² or kidney replacement therapy after ≥6 months, respectively) within individual AKRiS and precursor risk classes.

Results

GPA and MPA patients exhibited largely comparable baseline characteristics and treatment regimens. Histological analysis revealed that MPA biopsies showed significantly more sclerosis, interstitial fibrosis and tubular atrophy (IFTA) than their GPA counterparts. Histologically, most patients fell into focal and mixed classes, which mainly transitioned into low- and medium-risk AKRiS categories. Higher risk classifications predominantly derived from crescentic and sclerotic classes. Patients categorized as medium risk in the precursor score most frequently transitioned to lower AKRiS scores. AKRiS stratification was superior to the ANCA Renal Risk Score (ARRS) in the prediction of adverse outcomes over the entire period (AUC 0.76, C-Index 0.899).

Conclusions

The AKRiS score was found to be effective in predicting kidney failure and a strong composite kidney endpoint in a large European AAV cohort, despite slight differences in histological and event patterns between GPA and MPA under comparable treatment regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisDecision Support TechniquesGlomerulonephritisGranulomatosis with PolyangiitisKidneyMicroscopic PolyangiitisRenal InsufficiencyAdultAgedFemaleHumansMaleMiddle AgedBiopsyDisease ProgressionEuropeGlomerular Filtration RatePredictive Value of TestsRenal Replacement TherapyRetrospective StudiesRisk AssessmentRisk FactorsSeverity of Illness IndexTertiary Care CentersTime Factors

Stichwörter der Autor:innen

ANCAglomerulonephritisrisk scorevasculitis

Autor:innen und Institutionen

  • Department of Nephrology and Clinical Immunology, RWTH Aachen University Hospital, Pauwelsstraße 30, Aachen 52074, Germany.
  • Department of Internal Medicine III, University Hospital Jena, Friedrich-Schiller University, Jena, Germany.
  • Department of Internal Medicine A, Nephrology and Rheumatology, Municipal Hospital Ludwigshafen, Ludwigshafen, Germany.
  • Department of Rheumatology and Immunology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.

ORCID-Profile: Stefan Krämer, Kristian Vogt, Martin Busch, Raoul Bergner, Thomas Rauen

Förderung

  • Vifor Pharma Switzerland

Zitieren

APA

Krämer, S., Vogt, K., Busch, M., Schmitt, T., Bergner, R., Mosberger, S., Neumann, T., Schreibing, T. M., Schumbrink, F., & Rauen, T. (2026). Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteria. Journal of Nephrology, 39(1), 179-187. https://doi.org/10.1093/joneph/aajaf019

Vancouver

Krämer S, Vogt K, Busch M, Schmitt T, Bergner R, Mosberger S, et al. Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteria. Journal of Nephrology. 2026;39(1):179-187. doi:10.1093/joneph/aajaf019

BibTeX
@article{Krmer2026,
  author = {Krämer, Stefan and Vogt, Kristian and Busch, Martin and Schmitt, Tobias and Bergner, Raoul and Mosberger, Sebastian and Neumann, Thomas and Schreibing, Teresa Maria and Schumbrink, Fabian and Rauen, Thomas},
  title = {Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteria},
  journal = {Journal of Nephrology},
  year = {2026},
  volume = {39},
  number = {1},
  pages = {179--187},
  doi = {10.1093/joneph/aajaf019}
}
Kostenlos starten →